百克生物
(688276)
| 流通市值：82.11亿 | | | 总市值：82.11亿 |
| 流通股本：4.14亿 | | | 总股本：4.14亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 157,439,788.29 | 246,759,293.74 | 224,103,669.86 | 344,869,136.24 |
| 应收票据及应收账款 | 1,183,060,098.55 | 1,176,692,608.36 | 1,365,404,497.99 | 1,406,666,599.33 |
| 其中：应收票据 | - | - | 1,000,000 | 1,000,000 |
| 应收账款 | 1,183,060,098.55 | 1,176,692,608.36 | 1,364,404,497.99 | 1,405,666,599.33 |
| 预付款项 | 37,311,452.59 | 44,095,018.41 | 44,038,447.73 | 25,052,996.52 |
| 其他应收款合计 | 2,000,308.57 | 1,910,253.33 | 2,085,049.76 | 2,085,214.99 |
| 存货 | 232,401,508 | 278,753,114 | 211,195,454.4 | 170,776,028.1 |
| 其他流动资产 | 23,636,835.63 | 32,863,553.84 | 19,508,696.72 | 15,185,752.73 |
| 流动资产合计 | 1,635,849,991.63 | 1,781,073,841.68 | 1,866,335,816.46 | 1,964,635,727.91 |
| 非流动资产: | | | | |
| 长期股权投资 | 359,471,539.14 | 368,508,767.8 | 376,759,689.87 | 33,482,864.39 |
| 其他权益工具投资 | 17,682,019.14 | 20,630,607.33 | 22,838,486.82 | 177,856,876.94 |
| 固定资产 | 1,030,175,422.18 | 1,051,917,994.1 | 1,078,042,207.87 | 1,091,386,926.74 |
| 在建工程 | 1,537,956,925.57 | 1,495,505,460.53 | 1,461,383,150.11 | 1,386,382,013.65 |
| 无形资产 | 328,258,881.56 | 300,358,523.26 | 319,230,398.57 | 330,604,460.81 |
| 开发支出 | 39,356,465.88 | 5,033,579.69 | - | - |
| 长期待摊费用 | 88,506,631.71 | 66,768,347.13 | 71,830,216.8 | 74,675,730.9 |
| 递延所得税资产 | 140,135,532.62 | 119,425,642.69 | 101,553,253.6 | 96,281,759.54 |
| 其他非流动资产 | 32,803,234.62 | 55,464,508.54 | 54,213,660.08 | 49,562,476.67 |
| 非流动资产合计 | 3,574,346,652.42 | 3,483,613,431.07 | 3,485,851,063.72 | 3,240,233,109.64 |
| 资产总计 | 5,210,196,644.05 | 5,264,687,272.75 | 5,352,186,880.18 | 5,204,868,837.55 |
| 流动负债: | | | | |
| 短期借款 | 204,186,410.91 | 155,537,203.6 | 93,159,949.11 | 42,898,918.01 |
| 应付票据及应付账款 | 25,202,326.88 | 27,797,150.37 | 18,382,260.79 | 13,810,261.48 |
| 其中：应付票据 | - | - | 87,735 | 87,735 |
| 应付账款 | 25,202,326.88 | 27,797,150.37 | 18,294,525.79 | 13,722,526.48 |
| 合同负债 | 1,050,741.54 | 1,027,119.76 | 970,005.83 | 2,201,325.54 |
| 应付职工薪酬 | 27,836,777.86 | 28,214,009.54 | 19,625,459.73 | 28,072,774.39 |
| 应交税费 | 1,978,816.59 | 973,461.04 | 2,731,369.97 | 6,620,709.11 |
| 其他应付款合计 | 817,329,474.84 | 852,984,435.89 | 871,388,544.46 | 752,690,595.85 |
| 一年内到期的非流动负债 | 21,485,679.92 | - | - | - |
| 其他流动负债 | 73,817,216.6 | 9,469,024.85 | 38,856,873.8 | 70,771,900.07 |
| 流动负债合计 | 1,172,887,445.14 | 1,076,002,405.05 | 1,045,114,463.69 | 917,066,484.45 |
| 非流动负债: | | | | |
| 长期借款 | 70,415,797.86 | 107,844,630.08 | 82,061,861.15 | 59,929,861.15 |
| 预计负债 | 2,282 | 259,734.26 | 259,734.26 | 242,631.83 |
| 递延收益 | 8,485,515.95 | 8,436,692.08 | 8,724,182.21 | 9,000,358.34 |
| 递延所得税负债 | 806,370.55 | 831,324.3 | 856,278.04 | 881,231.79 |
| 非流动负债合计 | 79,709,966.36 | 117,372,380.72 | 91,902,055.66 | 70,054,083.11 |
| 负债合计 | 1,252,597,411.5 | 1,193,374,785.77 | 1,137,016,519.35 | 987,120,567.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 413,657,598 | 413,657,598 | 413,657,598 | 413,657,598 |
| 资本公积 | 1,817,437,284.1 | 1,843,967,146.68 | 1,841,402,483.3 | 1,840,287,470.97 |
| 其他综合收益 | -34,270,283.75 | -31,763,983.79 | -29,887,286.22 | -25,268,180.14 |
| 盈余公积 | 533,475,182 | 533,475,182 | 533,475,182 | 533,502,800.24 |
| 未分配利润 | 1,227,299,452.2 | 1,311,976,544.09 | 1,456,522,383.75 | 1,455,568,580.92 |
| 归属于母公司股东权益合计 | 3,957,599,232.55 | 4,071,312,486.98 | 4,215,170,360.83 | 4,217,748,269.99 |
| 股东权益合计 | 3,957,599,232.55 | 4,071,312,486.98 | 4,215,170,360.83 | 4,217,748,269.99 |
| 负债和股东权益合计 | 5,210,196,644.05 | 5,264,687,272.75 | 5,352,186,880.18 | 5,204,868,837.55 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-21 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |